Psychedelics induce profound changes in perception and thinking; however, little is known about the neural mechanisms and prediction of these effects.
Aims:
Investigating ayahuasca-induced experiences, mind-wandering, and electroencephalogram (EEG) oscillations, beyond the prediction of subjective experiences by baseline EEG.
Methods:
In a randomised, double-blind, placebo-controlled, parallel-arm design, 50 healthy volunteers received 1 mL/kg of ayahuasca or placebo. We measured subjective psychedelic experiences (Hallucinogen Rating Scale (HRS), Mystical Experience Questionnaire (MEQ)) and mind-wandering (Amsterdam Resting-State Questionnaire (ARSQ)). EEG signals were assessed before administration (+0h), and 2 hours (+2h) and 4 hours (+4h) post-administration. Relationships between subjective and EEG effects were examined.
Results:
Ayahuasca, compared to placebo, induced subjective experiences, including changed perception, cognition, emotion (HRS), mystical experiences (MEQ), and visual, discontinuous, and content-laden thinking (ARSQ). Ayahuasca, compared to placebo, changed EEG oscillations, including decreased global alpha as well as increased frontomedial delta and right posterior theta and beta. Under ayahuasca, lower theta correlated with higher mystical experiences (MEQ) and higher alpha correlated with lower Thoughts about Nothing (ARSQ). Baseline global EEG oscillations predicted ayahuasca-induced experiences, with lower theta linked to higher interoception (HRS Heart Beat, HRS Rush, ARSQ Somatic Awareness) and lower beta linked to higher positive emotionality (HRS Happy).
Conclusion:
Ayahuasca induced consciousness alterations, visual, bodily, emotional, and mystical experiences, chaotic and meaningful mind-wandering, and decreased especially alpha. While acute theta seems inversely related to mystical experiences, baseline theta and beta seem to inversely predict interoception and emotionality.
AdayJSDavisAKMitzkovitzCM, et al. (2021) Predicting reactions to psychedelic drugs: A systematic review of states and traits related to acute drug effects. ACS Pharmacology and Translational Science4(2): 424–435.
2.
ApudIScuroJCarreraI, et al. (2022) Psychological effects and subjective experiences of ayahuasca rituals in participants of two neoshamanic centers of Uruguay. Journal of Psychedelic Studies6(2): 72–79.
3.
BairdBMota-RolimSADreslerM (2019) The cognitive neuroscience of lucid dreaming. Neuroscience & Biobehavioral Reviews100: 305–323.
4.
BalconiMAngiolettiL (2021) One’s interoception affects the representation of seeing others’ pain: A randomized controlled qEEG study. Pain Research and Management2021: 5585060.
5.
BarbaTKettnerHRaduC, et al. (2024) Psychedelics and sexual functioning: A mixed-methods study. Scientific Reports14(1): 2181.
6.
BarrettFSGriffithsRR (2018) Classic hallucinogens and mystical experiences: Phenomenology and neural correlates. Behavioral Neurobiology of Psychedelic Drugs36: 393–430.
7.
BerryRBAlbertarioCLHardingSM, et al. (2018) The AASM Manual for the Scoring of Sleep and Associated Events: Rules. CiNii Research.
8.
BousoJCAndiónÓSarrisJJ, et al. (2022) Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Global Public Health2(11): 1–25. DOI: 10.1371/journal.pgph.0000438.
9.
BousoJCPedrero-pérezEJGandyS, et al. (2016) Measuring the subjective: Revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens. Human Psychopharmacology31: 356–372.
10.
BuschN. A.HerrmannC. S.MüllerM. M.LenzD.GruberT. (2006). A cross-laboratory study of event-related gamma activity in a standard object recognition paradigm. Neuroimage, 33(4): 1169–1177.
11.
CahnBRPolichJ (2006) Meditation states and traits: EEG, ERP, and neuroimaging studies. Psychological Bulletin132(2): 180–211.
12.
CahnBRDelormeAPolichJ (2013) Event-related delta, theta, alpha and gamma correlates to auditory oddball processing during vipassana meditation. Social Cognitive and Affective Neuroscience8(1): 100–111.
13.
Carhart-HarrisRLMuthukumaraswamySRosemanL, et al. (2016) Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences of the United States of America113(17): 4853–4858.
14.
Carhart-HarrisRLRosemanLHaijenECHM, et al. (2018) Psychedelics and the essential importance of context. Journal of Psychopharmacology32(7): 725–731.
15.
ChristoffKIrvingZCFoxKCRR, et al. (2016) Mind-wandering as spontaneous thought: A dynamic framework. Nature Reviews Neuroscience17(11): 718–731.
16.
CopaDErritzoeDGiribaldiB, et al. (2024) Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity. Journal of Affective Disorders353: 60–69.
17.
DadashiMBirashkBTaremianF, et al. (2015) Effects of increase in amplitude of occipital alpha & theta brain waves on global functioning level of patients with GAD. Basic and clinical neuroscience6(1): 14.
18.
de AlmeidaRNGalvãoACdeMda SilvaFS, et al. (2019) Modulation of serum brain-derived neurotrophic factor by a single dose of ayahuasca: Observation from a randomized controlled trial. Frontiers in Psychology10: 1234.
19.
DeLosAngelesDWilliamsGBurstonJ, et al. (2016) Electroencephalographic correlates of states of concentrative meditation. International Journal of Psychophysiology110: 27–39.
20.
DemiralpTBayraktarogluZLenzD, et al. (2007) Gamma amplitudes are coupled to theta phase in human EEG during visual perception. International Journal of Psychophysiology64(1): 24–30.
21.
DiazABHardstoneRMansvelderHD, et al. (2016) Resting-state subjective experience and EEG biomarkers are associated with sleep-onset latency. Frontiers in Psychology7: 492.
22.
DiazABVan Der SluisSBenjaminsJS, et al. (2014) The ARSQ 2.0 reveals age and personality effects on mind-wandering experiences. Frontiers in Psychology5: 271.
23.
DonNSMcDonoughBEMouraG, et al. (1998) Effects of Ayahuasca on the human EEG. Phytomedicine5(2): 87–96.
24.
Falchi-CarvalhoMPalhano-FontesFWießnerI, et al. (2025) Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: A phase 2a clinical trial in treatment-resistant depression. Neuropsychopharmacology50(6): 895–903.
25.
Falchi-CarvalhoMWießnerISilvaSRB, et al. (2024) Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial. European Neuropsychopharmacology80: 27–35.
26.
GalvãoACDMde AlmeidaRNSilvaEAdosS, et al. (2018) Cortisol modulation by ayahuasca in patients with treatment resistant depression and healthy controls. Frontiers in Psychiatry9: 185.
27.
Galvão-CoelhoNLGalvãoACDMAlmeidaRN De, et al. (2020) Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca. Journal of Psychopharmacology34(10): 1125–1133.
28.
HablitzLMVinitskyHSSunQ, et al. (2019) Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia. Science Advances5(2): eaav5447.
29.
HoffmannEHesselinkJMKBarbosaY-WMS (2001) Effects of a psychedelic, tropical tea, ayahuasca, on the Electroencephalographic (EEG) activity of the human brain during a shamanistic ritual. MAPS Bulletin11: 25–30.
30.
HolzeFVizeliPMüllerF, et al. (2020) Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects. Neuropsychopharmacology45(3): 462–471.
31.
HuelsERKimHLeeUC, et al. (2021) Neural correlates of the shamanic state of consciousness. Frontiers in Human Neuroscience15: 610466.
32.
International Center for Ethnobotanical Education Research and Service (2023) Ayahuasca, Global Consumption & Reported Deaths.
33.
KamJWYLinJJSolbakkAK, et al. (2019) Default network and frontoparietal control network theta connectivity supports internal attention. Nature Human Behaviour3(12): 1263–1270.
34.
KamJWYRahnumaTParkYE, et al. (2022) Electrophysiological markers of mind wandering: A systematic review. NeuroImage258: 119372.
35.
KangSSSponheimSRLimKO (2022) Interoception underlies therapeutic effects of mindfulness meditation for posttraumatic stress disorder: A randomized clinical trial. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging7(8): 793–804.
36.
KatyalSGoldinP (2021) Alpha and theta oscillations are inversely related to progressive levels of meditation depth. Neuroscience of Consciousness2021(1): niab042.
37.
KillingsworthMAGilbertDT (2010) A wandering mind is an unhappy mind. Science330(6006): 932.
38.
KlimeschW (1999) EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis. Brain Research Reviews29(2–3): 169–195.
KometerMPokornyTSeifritzE, et al. (2015) Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. Psychopharmacology232(19): 3663–3676.
41.
KraehenmannR (2017) Dreams and psychedelics: Neurophenomenological comparison and therapeutic implications. Current Neuropharmacology15(7): 1032–1042.
42.
KumarGPPandaRSharmaK, et al. (2024) Changes in high-order interaction measures of synergy and redundancy during non-ordinary states of consciousness induced by meditation, hypnosis, and auto-induced cognitive trance. NeuroImage293: 120623.
43.
KuypersKPCCRibaJde la Fuente RevengaM, et al. (2016) Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology233(18): 3395–3403.
44.
LebedevAVKaelenMLövdénM, et al. (2016) LSD-induced entropic brain activity predicts subsequent personality change. Human Brain Mapping37(9): 3203–3213.
45.
LeunerH (1962) Die Experimentelle Psychose – Ihre Psychopharmakologie, Phänomenologie Und Dynamik in Beziehung Zu Person. Springer-Verlag.
46.
LeyLHolzeFArikciD, et al. (2023) Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. Neuropsychopharmacology48(11): 1659–1667.
47.
MaiaLODaldegan-BuenoDWießnerI, et al. (2023) Ayahuasca’s therapeutic potential: What we know – And what not. European Neuropsychopharmacology66: 45–61.
48.
MurrayCHFrohlichJHaggartyCJ, et al. (2024) Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine. Neuropsychopharmacology49(7): 1120–1128.
49.
MuthukumaraswamySDCarhart-HarrisRLMoranRJ, et al. (2013) Broadband cortical desynchronization underlies the human psychedelic state. Journal of Neuroscience33(38): 15171–15183.
50.
NiedermeyerE (2011) Niedermeyer’s Electroencephalography: Basic Principles, Clinical Applications, and Related Fields. Lippincott Williams & Wilkins.
51.
NiedernhuberMStreicherJLeggenhagerB, et al. (2024) Attention and interoception alter perceptual and neural pain signatures: A case study. Journal of Pain Research17: 2393–2405.
52.
NoreikaVCanales-JohnsonAKohJ, et al. (2015) Intrusions of a drowsy mind: Neural markers of phenomenological unpredictability. Frontiers in Psychology6: 202.
53.
Omágua-KambebaALabateBCRibeiroS (2023) Psychedelic science and Indigenous shamanism: An urgent dialogue. Nature Mental Health1(11): 815–816.
54.
Palhano-FontesFAndradeKCTofoliLF, et al. (2015) The psychedelic state induced by Ayahuasca modulates the activity and connectivity of the Default Mode Network. PLoS One10(2): e0118143.
55.
Palhano-FontesFBarretoDOniasH, et al. (2019) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychological Medicine49(4): 655–663.
56.
PallaviciniCCavannaFZamberlanF, et al. (2021) Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings. Journal of Psychopharmacology35(4): 406–420. DOI: 10.1177/0269881120981384.
57.
PallaviciniCVilasMGVillarrealM, et al. (2019) Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives. NeuroImage200: 281–291.
58.
PasquiniLPalhano-fontesFAraujo DraulioB, et al. (2020) Subacute effects of the psychedelic ayahuasca on the salience and default mode networks. Journal of Psychopharmacology34: 623–635.
59.
PipinisEMelynyteSKoenigT, et al. (2017) Association between resting-state microstates and ratings on the Amsterdam Resting-State Questionnaire. Brain Topography30(2): 245–248.
60.
ReckwegJMasonNLLeeuwenC Van, et al. (2021) A phase 1, dose-ranging study to assess safety and psychoactive effects of a vaporized 5-methoxy-N, N- dimethyltryptamine formulation (GH001) in healthy volunteers. Frontiers in Pharmacology12: 760671.
61.
RibaJAndererPJanéF, et al. (2004) Effects of the South American psychoactive beverage Ayahuasca on regional brain electrical activity in humans: A functional neuroimaging study using low-resolution electromagnetic tomography. Neuropsychobiology50(1): 89–101.
62.
RibaJAndererPMorteA, et al. (2002) Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. British Journal of Clinical Pharmacology53(6): 613–628.
63.
RibaJValleMUrbanoG, et al. (2003) Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics306(1): 73–83.
64.
RodriguesRSWießnerIDaldegan-BuenoD, et al. (2025) OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study. Journal of Psychopharmacology39: 990–1006.
65.
RosemanLNuttDJCarhart-HarrisRL (2018) Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology8: 974.
66.
RubanAMagnuskiMHobotJ, et al. (2024) Processing of self-related thoughts in experienced users of classic psychedelics: A source localisation EEG study. Progress in Neuro-Psychopharmacology and Biological Psychiatry136: 111196.
67.
SanzCTagliazucchiE (2018) The experience elicited by hallucinogens presents the highest similarity to dreaming within a large database of psychoactive substance reports. Frontiers in Neuroscience12: 7.
68.
SausengPGriesmayrBFreunbergerR, et al. (2010) Control mechanisms in working memory: A possible function of EEG theta oscillations. Neuroscience and Biobehavioral Reviews34(7): 1015–1022.
69.
SayinÜ (2012) A comparative review of the neuro-psychopharmacology of hallucinogen-induced altered states of consciousness: The uniqueness of some hallucinogens. NeuroQuantology10(2): 316–340.
70.
SchenbergEEAlexandreJFMFilevR, et al. (2015) Acute biphasic effects of ayahuasca. PLoS One10(9): e0137202.
71.
SchenbergEETófoliLFRezinovskyD, et al. (2017) Translation and cultural adaptation of the states of consciousness questionnaire (SOCQ) and statistical validation of the mystical experience questionnaire (MEQ30) in brazilian portuguese. Revista de Psiquiatria Clinica44(1): 1–5.
72.
SodréMEWießnerIIrfanM, et al. (2023) Awake or sleeping? Maybe both. . . A review of sleep-related dissociative states. Journal of Clinical Medicine12(12): 3876.
73.
StrijkstraAMBeersmaDGMDrayerB, et al. (2003) Subjective sleepiness correlates negatively with global alpha (8–12 Hz) and positively with central frontal theta (4–8 Hz) frequencies in the human resting awake electroencephalogram. Neuroscience Letters340(1): 17–20.
74.
StuderusEKometerMHaslerF, et al. (2011) Acute, subacute and long-term subjective effects of psilocybin in healthy humans: A pooled analysis of experimental studies. Journal of Psychopharmacology25(11): 1434–1452.
75.
TagliazucchiEZamberlanFCavannaF, et al. (2021) Baseline power of theta oscillations predicts mystical-type experiences induced by DMT in a natural setting. Frontiers in Psychology12: 720066.
76.
TimmermannCBauerPRGosseriesO, et al. (2023a) A neurophenomenological approach to non-ordinary states of consciousness: Hypnosis, meditation, and psychedelics. Trends in Cognitive Sciences27(2): 139–159.
77.
TimmermannCRosemanLHaridasS, et al. (2023b) Human brain effects of DMT assessed via EEG-fMRI. Proceedings of the National Academy of Sciences of the United States of America120: e2218949120.
78.
TimmermannCRosemanLSchartnerM, et al. (2019) Neural correlates of the DMT experience assessed with multivariate EEG. Scientific Reports9(1): 16324.
79.
TimmermannCRosemanLWilliamsL, et al. (2018) DMT models the near-death experience. Frontiers in Psychology9: 1424.
80.
ValleMMaquedaAERabellaM, et al. (2016) Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans. European Neuropsychopharmacology26(7): 1161–1175.
81.
ViolAPalhano-FontesFOniasH, et al. (2017) Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca. Scientific Reports7(1): 7388.
82.
VogtSBLeyLErneL, et al. (2023) Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Translational Psychiatry13(1): 172.
83.
WießnerIFalchiMMaiaLO, et al. (2022) LSD and creativity: Increased novelty and symbolic thinking, descreased utility and convergent thinking. Journal of Psychopharmacology36(3): 348–359.
84.
WießnerIFalchiMPalhano-FontesF, et al. (2021) Low-dose LSD and the stream of thought: Increased discontinuity of mind, deep thoughts and abstract flow. Psychopharmacology239(6): 1721–1733.
85.
WießnerIFalchiMPalhano-FontesF, et al. (2023) LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model. Psychological Medicine53(4): 1151–1165.
86.
WießnerIFalchi-CarvalhoMLabordeS, et al. (2025) Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial. European Neuropsychopharmacology97: 16–27.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
